Psoriasis treatment is evolving through better understanding of patients with
psoriasis and the pathogenesis of the disease itself. Current treatment plans for
psoriasis consist of topical medications for mild-moderate or localized
psoriasis and more systemic agents for more generalized and moderate-severe
psoriasis. New methods of treatment involve not only prescriptions, but patient education and support through organizations such as the National
Psoriasis Foundation. The effectiveness of topical treatments have been improved by a better understanding of increasing patients' adherence to medications and new treatments--new vehicles and combination treatments--that enhance patients' adherence behaviors.
Phototherapy, with or without an oral
retinoid, remains a key component of
psoriasis treatment. More convenient and specific monitoring of
methotrexate and
biologic medications provide these standards of care in
psoriasis better and safer patient outcomes. New anti-
IL-12/23
therapies offer another more specific option in the management of chronic plaque
psoriasis. Dermatologists should recognize and educate patients about the recently recognized association between
psoriasis and
vascular disease.
Psoriasis management can include counseling patients to obtain appropriate screening for cardiovascular risk.